{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Ritchie+of+Downpatrick&min-answer.questionFirstAnswered.=2024-04-29T16%3A40%3A27.493Z&max-date=2024-05-13", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Baroness+Ritchie+of+Downpatrick&min-answer.questionFirstAnswered.=2024-04-29T16%3A40%3A27.493Z&max-date=2024-05-13", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Ritchie+of+Downpatrick&min-answer.questionFirstAnswered.=2024-04-29T16%3A40%3A27.493Z&max-date=2024-05-13&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Ritchie+of+Downpatrick&_page=0&min-answer.questionFirstAnswered.=2024-04-29T16%3A40%3A27.493Z&max-date=2024-05-13", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Ritchie+of+Downpatrick&min-answer.questionFirstAnswered.=2024-04-29T16%3A40%3A27.493Z&max-date=2024-05-13", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Ritchie+of+Downpatrick&min-answer.questionFirstAnswered.=2024-04-29T16%3A40%3A27.493Z&max-date=2024-05-13", "items" : [{"_about" : "http://data.parliament.uk/resources/1717431", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1717431/answer", "answerText" : {"_value" : "
The UK Health Security Agency monitors national immunisation programmes in England, and will monitor the implementation of any future protection immunisation programmes for older adults and infants. This includes immunisation coverage, immunisation effectiveness at preventing disease, including the duration of the protective effect, the overall impact of the immunisation programme, and any safety signals. This real-world data will be shared with the Joint Committee on Vaccination and Immunisation and the Department, to inform future policy including future eligibility.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2024-05-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-23T12:22:41.13Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-05-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Respiratory Syncytial Virus: Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government whether they plan to generate real-world data on any future RSV immunisation programme for older adults and infants and, if so, how such data would be used to inform future eligibility.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4130", "label" : {"_value" : "Biography information for Baroness Ritchie of Downpatrick"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Ritchie of Downpatrick"} ], "uin" : "HL4596"} , {"_about" : "http://data.parliament.uk/resources/1717432", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1717432/answer", "answerText" : {"_value" : "
The Government have made a policy decision on the eligibility of a potential respiratory snncytial virus (RSV) programme, which is in line with the Joint Committee of Vaccination and Immunisation\u2019s (JCVI) September 2023 advice.<\/p>
When a new immunisation programme is introduced, policy decisions are made about who the National Health Service will offer the immunisation to. These decisions are based on the advice and recommendations of the JCVI. The eligibility of an immunisation programme is not reviewed in a time-based manner, although the JCVI keeps all immunisation programmes and advice under review and can update its advice based on new and emerging data.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2024-05-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-23T14:34:14.227Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-05-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Respiratory Syncytial Virus: Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what plans they have to review eligibility for any future RSV immunisation programme, and whether such a review would be based on timing or on assessment of data.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4130", "label" : {"_value" : "Biography information for Baroness Ritchie of Downpatrick"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Ritchie of Downpatrick"} ], "uin" : "HL4597"} , {"_about" : "http://data.parliament.uk/resources/1717433", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1717433/answer", "answerText" : {"_value" : "
The Department continues to work across the health system, with the devolved administrations, to deliver robust, cost-effective programmes which benefit public health. The Joint Committee for Vaccination and Immunisation (JCVI) advises on the approach to immunisation, and also evaluates opportunities to deliver robust, cost-effective programmes that protect public health. Investments in vaccines and other health interventions are assessed for cost effectiveness within a broader framework that allows one intervention to be assessed fairly alongside another.<\/p>
While the JCVI does not consider productivity and economic outcomes, the Department can still opt to consider the productivity and economic impacts of immunisation, where this is judged to be an important additional consideration, in line with His Majesty's Treasury\u2019s Green Book guidance.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2024-05-23", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL4599"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-23T12:01:06.243Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-05-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what plans they have to evaluate and understand the impact of immunisation programmes on productivity and economic outcomes.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4130", "label" : {"_value" : "Biography information for Baroness Ritchie of Downpatrick"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Ritchie of Downpatrick"} ], "uin" : "HL4598"} , {"_about" : "http://data.parliament.uk/resources/1717434", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1717434/answer", "answerText" : {"_value" : "
The Department continues to work across the health system, with the devolved administrations, to deliver robust, cost-effective programmes which benefit public health. The Joint Committee for Vaccination and Immunisation (JCVI) advises on the approach to immunisation, and also evaluates opportunities to deliver robust, cost-effective programmes that protect public health. Investments in vaccines and other health interventions are assessed for cost effectiveness within a broader framework that allows one intervention to be assessed fairly alongside another.<\/p>
While the JCVI does not consider productivity and economic outcomes, the Department can still opt to consider the productivity and economic impacts of immunisation, where this is judged to be an important additional consideration, in line with His Majesty's Treasury\u2019s Green Book guidance.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2024-05-23", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL4598"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-23T12:01:06.293Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-05-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what plans they have to work with NHS England and with the devolved administrations to ensure that socioeconomic benefits from immunisation, including those relating to productivity, can be fully realised in the UK.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4130", "label" : {"_value" : "Biography information for Baroness Ritchie of Downpatrick"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Ritchie of Downpatrick"} ], "uin" : "HL4599"} , {"_about" : "http://data.parliament.uk/resources/1717435", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1717435/answer", "answerText" : {"_value" : "
The Department has well-established policies and mechanisms in place to ensure health programmes and investments are subject to systematic evaluation at key stages in their lifecycle, in accordance with HM Treasury\u2019s business case guidance. This includes reviewing quantitative and qualitative evidence on whether approved health projects achieve their objectives and deliver the promised benefits within the agreed budget, timescale, and scope. Lessons from post-project evaluation are widely disseminated, to support better investment decisions in future, and more robustly developed business cases.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2024-05-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-20T10:34:42.307Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-05-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health: Productivity"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what plans they have to enable evaluation of health programmes and investments to account for productivity benefits, in line with guidance issued in the Green Book.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4130", "label" : {"_value" : "Biography information for Baroness Ritchie of Downpatrick"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Ritchie of Downpatrick"} ], "uin" : "HL4600"} , {"_about" : "http://data.parliament.uk/resources/1717436", "AnsweringBody" : [{"_value" : "Department for Work and Pensions"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1717436/answer", "answerText" : {"_value" : "
The latest published statistics show for households sent a migration notice between April 2023 and end of March 2024, and who went on to claim Universal Credit, 60% were awarded transitional protection.<\/p>
<\/p>